Literature DB >> 16790584

Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.

Soheil Meshinchi, Robert J Arceci, Jean E Sanders, Franklin O Smith, William B Woods, Jerald P Radich, Todd A Alonzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16790584     DOI： 10.1182/blood-2005-12-4938

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

Review 1.  Who is fit for allogeneic transplantation?

Authors:  H Joachim Deeg; Brenda M Sandmaier
Journal:  Blood       Date:  2010-08-11       Impact factor: 22.113

2.  Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.

Authors:  Zhichao Li; Yinmei Liu; Qing Wang; Linjun Chen; Liyuan Ma; Siguo Hao
Journal:  Acta Haematol       Date:  2019-02-26       Impact factor: 2.195

Review 3.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 4.  The Future of Targeting FLT3 Activation in AML.

Authors:  Mark B Leick; Mark J Levis
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

5.  Clinical implications of FLT3 mutations in pediatric AML.

Authors:  Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Michel Zwaan; Martin Zimmerman; Dirk Reinhardt; Gertjan J L Kaspers; Nyla A Heerema; Robert Gerbing; Beverly J Lange; Jerald P Radich
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

6.  How I treat FLT3-mutated AML.

Authors:  Keith W Pratz; Mark Levis
Journal:  Blood       Date:  2016-11-21       Impact factor: 22.113

7.  Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Todd A Alonzo; Michael R Loken; Robert B Gerbing; Rhonda E Ries; Richard Aplenc; Lillian Sung; Susana C Raimondi; Betsy A Hirsch; Samir B Kahwash; Amy McKenney; E Anders Kolb; Alan S Gamis; Soheil Meshinchi
Journal:  Clin Cancer Res       Date:  2017-01-20       Impact factor: 12.531

8.  High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.

Authors:  Hyoung Jin Kang; Ji Won Lee; Sang Hyeok Kho; Min Jeong Kim; Young Jin Seo; Hyery Kim; Hee Young Shin; Hyo Seop Ahn
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

Review 9.  Childhood acute myeloid leukaemia.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba
Journal:  Br J Haematol       Date:  2012-09-12       Impact factor: 6.998

Review 10.  Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation.

Authors:  Carlos Best-Aguilera; O Rodrigo Gómez-Vázquez; A Elizabeth Guzmán-Hernández; R Monserrat Rojas-Sotelo
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.